Clinical trial
Randomized, Controlled, Double-Masked, Multicenter, Exploratory Study of the Clinical Benefit and Safety of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR) Using a Coaxial Phacoemulsification Process
NCT00721695 is registered in ClinicalTrials.gov with Omeros Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled, Double-Masked, Multicenter, Exploratory Study of the Clinical Benefit and Safety of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR) Using a Coaxial Phacoemulsification Process
- Lead sponsor
- Omeros Corporation
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- February 28, 2009
- Enrollment
- 60 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cataract extraction